Yocca Frank
Chief Scientific Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 35 | — | — | filing |
| 2026-05-20 | BTAI | BioXcel Therapeutics, Inc. | Sale | 6,845 | $1.09 | $7,426.83 | filing |
| 2026-05-04 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 17,500 | — | — | filing |
| 2026-05-01 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 9,000 | — | — | filing |
| 2026-03-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 35 | — | — | filing |
| 2026-03-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 33 | — | — | filing |
| 2025-12-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 35 | — | — | filing |
| 2025-12-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 33 | — | — | filing |
| 2025-09-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 35 | — | — | filing |
| 2025-09-14 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 33 | — | — | filing |
| 2025-07-22 | BTAI | BioXcel Therapeutics, Inc. | Award | 4,375 | — | — | filing |
| 2025-06-15 | BTAI | BioXcel Therapeutics, Inc. | Option exercise | 35 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.